Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
December 07, 2025 16:00 ET | Source: Wave Life Sciences USA, Inc.…
RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherbys Transparency Initiative
New York, NY, Dec. 06, 2025 (GLOBE NEWSWIRE) -- RadiantVibe Capital Consortium…
BI DeFi Launches New Daily Yield Plan as Demand for Accessible Crypto Income Solutions Grows
New York, USA, Dec. 06, 2025 (GLOBE NEWSWIRE) -- BI DeFi has…
Humanoid Global Welcomes Marc Theermann, Chief Strategy Officer of Boston Dynamics to its Technical Advisory Committee
December 05, 2025 16:00 ET | Source: Humanoid Global Holdings Corp. –…
TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 06, 2025 17:30 ET | Source: TScan Therapeutics, Inc. Treatment arm…
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear…
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
Selective Treg modulator gotistobart (BNT316/ONC-392) showed a reduction in the risk of…
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
December 05, 2025 17:00 ET | Source: Rocket Doctor AI Inc. Vancouver,…
Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing
BEIJING, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Global Mofy AI Limited (the…
MiLi Christmas Limited Edition Christmas Gift Ideas That Shines Beyond the Holidays
Shenzhen, Dec. 05, 2025 (GLOBE NEWSWIRE) -- This Christmas, MiLi introduces something…
